Luis Francisco Lorenzo-Martín

21PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsSolid tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Dec 15, 2025
Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis-refractory state.

Ludivine Bersier, L Francisco Lorenzo-Martin, Yi-Hsuan Chiang

|Dec 03, 2025
Bioengineering mini-colons for ex vivo colorectal cancer research.

L Francisco Lorenzo-Martín, Tania Hübscher, Jakob Langer

|Mar 31, 2025
Active R-RAS2/TC21 prevents cell cycle arrest and morphological alterations in mouse embryonic fibroblasts lacking RAS proteins.

Isabel Fernández-Pisonero, L Francisco Lorenzo-Martín, Mattias Drosten

|Aug 14, 2024
Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroids.

Devanjali Dutta, L Francisco Lorenzo-Martín, François Rivest

|Jul 02, 2024
Patient-derived mini-colons enable long-term modeling of tumor-microenvironment complexity.

L Francisco Lorenzo-Martín, Nicolas Broguiere, Jakob Langer

|Jun 05, 2024
Mini-colons unlock tumour development outside the body.

L Francisco Lorenzo-Martín, Matthias P Lutolf

Pageof 4

Frequent Collaborators

14 joint publications

Xosé R Bustelo

7 joint publications

Sonia Rodríguez-Fdez

5 joint publications

Matthias P Lutolf

4 joint publications

Isabel Fernández-Pisonero